Market Overview
The global Organ on Chip market is valued at US$ 9.40 Mn in 2018 and is expected to grow at a CAGR of 16.6% over the forecast period to reach a US$ 31.85 Mn by 2026.
The market players are adopting various key strategies such as collaborations, product launches, mergers & acquisitions, and partnerships to expand their business contributing to the growth of the organ-on-chip market. For instance,
In July 2019, InSphero AG launched a 3D InSightTM Human Liver Disease Discovery Platform for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). The platform has been precisely engineered to include all the human liver cell types and inducers necessary to replicate the progression of NASH in patients, from fatty liver (steatosis) to inflammation (NASH) and scarring (fibrosis) of the liver.
Market Dynamics
Surge in demand for organ-on-chip devices in the healthcare industry is expected to boost the growth of the global organ-on-chip market. Real-time imaging, in-vitro analysis of biochemical, and genetic & metabolic activities of living cells in functional tissues are some of the applications of organ-on-chip devices in the industry.
Advancements in cell biology, microfabrication, and microfluidics have led to increasing in the adoption of organ-on-chips, thereby fueling the growth of the market.
Drug screening is a cost-effective method used to rapidly review all samples.
Scientists and researchers use organon-chip culture devices to monitor the effects of drugs in the body.
The shortage of donor’s lungs for transplantation has led to a significant number of patient deaths.
Download Sample Brochure @ https://www.datamintelligence.com/download-sample/organ-on-chip-market
Market Segmentation
- By Model
- By End-Users
- By Region
By Model – Lung-On-Chip
Lung-on-chip is the first developed prototype of organ model by Harvard University’s Wyss Institute. The lung-on-chip model basically mimics lung epithelium.
Lung-on-chip organ models are designed using the human lung and blood vessel cells. It acts as a multifunctional model that has the potential to emulate key structural, functional and mechanical properties of the human alveolar-capillary interface. Lung-on-chip is mainly used to study the airway closure and opening, lung inflammation, airway protein synthesis, pulmonary absorption. These models are also primarily used in drug screening and lead generation process.
Geographical Analysis – North America:
North America includes U.S., Canada, and Mexico. The growth of the North America organ on-chips market is driven by surge in adoption of organ-on-chips over 2D and 3D cell cultures. Furthermore, rise in demand for OOCs in drug screening, especially in the U.S., and increase in number of key players of OOCs in North America are expected to fuel the growth of the market in the coming years.
Organ-on-chip cell culture devices considerably reduce costs in the initial stage of product development in the biotechnology research, which significantly fuels the growth of the market.
Moreover, advancements in cell biology, microfabrication, and microfluidics have led to the development of OOCs. Such microfluidic models are used to cure various life threatening diseases such as cancer or asthma, and provide researchers with a cost-effective mini laboratory for introducing immune cells or drugs and observing reactions in real time.
Competitive Analysis – Emulate
Emulate, Inc. was founded in 2013 and is based in Boston, Massachusetts.
The company develops organs-on-chips human emulation technology solutions to emulate human biology to understand how diseases, medicines, chemicals, and food affect human health.
Its products include organ-chips that cover lung, intestine, liver, and skin that recapitulates normal function and disease states; and instrumentation and software apps for R&D workflows of end-users.
The company’s system covers drug development applications. It serves customers in biotechnology, pharmaceutical, consumer health, cosmetics, chemical, food, agrochemicals, government agencies, academic researchers, and personalized health markets.
Organs-on-Chips technology at the Wyss Institute for Biologically Inspired Engineering at Harvard University. The company holds the worldwide exclusive license from Harvard University to a robust and broad intellectual property portfolio for Organs-on-Chips technology and related systems.
Trending Reports
Hemodynamic Flow Alteration Devices Market
Epilepsy Monitoring Devices Market
About Us:
DataM Intelligence was established on an elemental idea of publishing Advanced Market Research Reports with precise data points & utmost accuracy that will accelerate the decision-making in designing disruptive solutions.
Media Contact:
Name: Sai Kiran
Company: DataM Intelligence
Contact No: +1 8774414866
Email us: info@datamintelligence.com